ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1801–1812 of 2020 project topics
PKD1 and PKD2 Comprehensive Molecular Testing
Developing optimized PKD1 and PKD2 sequencing approaches overcoming PKD1 pseudogene challenges for accurate ADPKD molecular diagnosis.
Genetic Basis of Autosomal Dominant Polycystic Kidney Disease Click to view more details →
ADPKD Genotype-Renal Outcome Correlation
Correlating PKD1 truncating versus non-truncating and PKD2 mutation status with kidney volume growth and age at renal failure for prognosis.
Genetic Basis of Autosomal Dominant Polycystic Kidney Disease Click to view more details →
Tolvaptan Eligibility Genetic Stratification
Determining how ADPKD genotype influences tolvaptan vasopressin receptor antagonist eligibility and benefit for personalized treatment decisions.
Genetic Basis of Autosomal Dominant Polycystic Kidney Disease Click to view more details →
GANAB and DNAJB11 ADPKD Variant Analysis
Characterizing GANAB and DNAJB11 mild ADPKD gene variants for molecular diagnosis in patients with atypical or mild polycystic kidney disease.
Genetic Basis of Autosomal Dominant Polycystic Kidney Disease Click to view more details →
Real-time ADPKD Progression Risk Prediction SaaS Platform
A cloud-based analytics platform that integrates PKD1/PKD2 genetic data with clinical biomarkers to predict kidney function decline velocity in ADPKD patients. Enables pharmaceutical companies and CROs to identify high-risk patient cohorts for clinical trials, reducing trial duration and improving drug approval timelines.
Genetic Basis of Autosomal Dominant Polycystic Kidney Disease Click to view more details →
Variant Interpretation and Reporting Workflow Automation Tool
An intelligent software solution that automatically classifies rare and novel ADPKD-causing variants using established pathogenicity frameworks and variant databases. Reduces laboratory turnaround time by 60%, enabling diagnostic labs to scale operations and increase reimbursement revenue per test.
Genetic Basis of Autosomal Dominant Polycystic Kidney Disease Click to view more details →
Multi-Gene ADPKD Panel Design and Optimization Service
A specialized genomic panel customization service targeting rare monogenic ADPKD genes including SEC63, IFT88, and PKHD1 alongside standard PKD genes. Creates defensible competitive advantage for genetic testing companies entering the pediatric and atypical ADPKD diagnostic market.
Genetic Basis of Autosomal Dominant Polycystic Kidney Disease Click to view more details →
Patient-Centric Pharmacogenomic ADPKD Precision Medicine Platform
An integrated digital health platform that matches ADPKD patients to optimal therapies based on PKD1/PKD2 mutation class and secondary modifying genetic variants. Enables pharmaceutical manufacturers to establish direct-to-patient engagement programs, driving medication adherence and generating real-world outcome data for market differentiation.
Genetic Basis of Autosomal Dominant Polycystic Kidney Disease Click to view more details →
Enterprise Genetic Data Integration and Clinical Analytics Suite
A HIPAA-compliant data aggregation platform that harmonizes ADPKD genetic findings across multi-institutional health systems to build proprietary outcome registries. Generates high-value datasets for biotech licensing agreements, payer health economic models, and precision medicine strategy consulting.
Genetic Basis of Autosomal Dominant Polycystic Kidney Disease Click to view more details →
AI-Powered Genotype Phenotype Correlation Prediction Engine
A machine learning platform that identifies complex genetic modifiers influencing ADPKD disease severity and medication response through multi-omics pattern recognition. Delivers actionable clinical insights to nephrologists via licensed API integration, creating recurring SaaS subscription revenue and clinical decision support market expansion.
Genetic Basis of Autosomal Dominant Polycystic Kidney Disease Click to view more details →
SPG4 SPAST Gene Comprehensive Testing
Developing comprehensive SPAST testing including sequencing and MLPA for the most common HSP form and predicting age of onset from genotype.
Genetic Basis of Hereditary Spastic Paraplegia Click to view more details →
Complex HSP Gene Panel for Diagnosis
Creating comprehensive gene panels for complex HSP subtypes including SPG7, SPG11, SPG15, and SPG21 for molecular diagnosis.
Genetic Basis of Hereditary Spastic Paraplegia Click to view more details →